Abbott Compound definition

Abbott Compound means any synthetic chemical compound or biological material, which compound or material:
Sample 1Sample 2Sample 3
Abbott Compound means an Abboxx Xxxe Compound (as defined below) or an Abbott Derivative Compound (as defined below).
Sample 1Sample 2
Abbott Compound means a small molecule that (1) was first discovered in the Research Program to have activity in the Excluded Field and for which structural information and the information related to such activity was provided to ICOS and (2) is a Research Compound. "Derived Product" means an Excluded Product containing a Research Compound whose structure was derived by ICOS from an Abbott Compound (or a salt or prodrug thereof). "Direct Product" shall mean an Excluded Product containing a Research Compound that is an Abbott Compound (or a salt, prodrug or trivial chemical variation (e.g., methylated analog) thereof). "SAR by NMR Product" shall mean an Excluded Product containing a Research Compound whose structure was developed by the SAR by NMR research work performed by Abbott for ICOS (or a salt, prodrug or trivial chemical variation thereof). "Final Product" means a Derived Product, Direct Product, or SAR by NMR Product. The definitions of "Net Sales" and "Royalty Period" shall be applied mutatis mutandis to ICOS and Final Products. All other terms shall have the meaning set forth in this Agreement. B. Royalties. Subject to the terms of this Exhibit B, ICOS shall pay Abbott a royalty on the Net Sales during the Royalty Period of Excluded Products that are Final Products as follows: (1) On a country-by-country basis with respect to each Final Product that is made, used or sold in a country in which it is covered by a patent (until the date set forth in Section 1.37(a) with respect Valid Claims covering use or method of manufacture),the royalty rate shall be: Product Rate Direct Product [ * ] Derived Product [ * ] SAR by NMR Product [ * ] SAR by NMR Products ------------------- Net Sales During Contract Year Royalty Rate [ * ] [ * ]
Sample 1

Examples of Abbott Compound in a sentence

  • Icagen acknowledges and agrees that Abbott shall have no obligation to include any Encumbered Abbott Compound in the Research Program.

  • ICOS shall notify Abbott within [ * ] after receiving structural information for such Abbott Compound from Abbott that it has the same or related structural information from other work or other sources; otherwise, ICOS shall have the burden of proving that such Abbott Compound or compound incorporated in the Final Product was not derived from the structural information provided to ICOS by Abbott.

  • For purposes of clarity, the Parties hereby acknowledge and agree that no Compound or Abbott Compound may be Developed under the Development Program unless and until it is designated as a Candidate by the JSC.

  • Within [*****] days after its receipt of each report from a Party pursuant to Section 3.5(b) identifying a Compound or Abbott Compound which such Party determines be Developed as a Candidate, the JSC shall (i) review such supporting data and information using standards and criteria to be developed by the JSC, and (ii) if it determines that a Candidate has been identified, notify the Parties in writing of such determination (each, a “Candidate Designation”).

  • As used in this Exhibit B: "Abbott Compound" means a small molecule that (1) was first discovered in the Research Program to have activity in the Excluded Field and for which structural information and the information related to such activity was provided to ICOS and (2) is a Research Compound.

  • Upon the issuance by the JSC of a Candidate Designation for a Compound or Abbott Compound, (a) such Compound or Abbott Compound shall be deemed to be a Candidate for purposes of this Agreement and (b) the Parties shall, asConfidential materials omitted and filed separately with the Securities and Exchange Commission.

Related to Abbott Compound

  • Licensed Compound means [***].

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Compounds means a small molecule HMT inhibitor.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Commercialized shall have corresponding meanings.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Program Patent Rights means any Patent Rights that are Controlled by one or both parties and that Cover any Program Technology or Program Materials. For clarification, such Program Patent Rights include the entire scope of all of the claims contained in such Patent Rights.

  • Combination Product means a product (a) containing a Licensed Product together with one or more other active ingredients, or (b) with one or more products, devices, pieces of equipment or components, but sold for an integrated price (e.g., with the purchase of one product the customer gets a coupon for the other) or for a single price.

  • Commercialization or “Commercialize” means any and all activities undertaken at any time for a particular Licensed Product and that relate to the manufacturing, marketing, promoting, distributing, importing or exporting for sale, offering for sale, and selling of the Licensed Product, and interacting with Regulatory Authorities regarding the foregoing.